Infectious Mediastinitis Among the Strasbourg Universitary Hospital
MEDIASTINITIS
1 other identifier
observational
100
1 country
1
Brief Summary
Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedDecember 2, 2021
August 1, 2021
11 months
August 6, 2021
November 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg
Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]
Eligibility Criteria
Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020
You may qualify if:
- Major subject (≥18 years old)
- Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020
- Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.
You may not qualify if:
- Subject having expressed opposition to participate in the study
- Subject under guardianship, curatorship or safeguard of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yvon RUCH, MD
Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 11, 2021
Study Start
June 1, 2021
Primary Completion
May 1, 2022
Study Completion
May 31, 2022
Last Updated
December 2, 2021
Record last verified: 2021-08